Corcept Therapeutics 2024年第四季度GAAP每股收益$0.26,未达到预期的$0.42,销售额$1.819亿未达到预期的$1.98686亿

财报速递02-27
Corcept Therapeutics (NASDAQ:CORT) 报告季度每股收益为$0.26,比分析师一致预期的$0.42低38.1%。这相比去年同期每股收益$0.28下降了7.14%。公司报告季度销售额为$1.819亿,比分析师一致预期的$1.98686亿低8.45%。这相比去年同期的销售额$1.35405亿增长了34.34%。

以上内容来自Benzinga Earnings专栏,原文如下:

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.42 by 38.1 percent. This is a 7.14 percent decrease over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $181.900 million which missed the analyst consensus estimate of $198.686 million by 8.45 percent. This is a 34.34 percent increase over sales of $135.405 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法